Flavonoid Apigenin Is an Inhibitor of the NAD(+)ase CD38: Implications for Cellular NAD(+) Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

Metabolic syndrome is a growing health problem worldwide. It is therefore imperative to develop new strategies to treat this pathology. In the past years, the manipulation of NAD(+) metabolism has emerged as a plausible strategy to ameliorate metabolic syndrome. In particular, an increase in cellula...

Descripción completa

Detalles Bibliográficos
Autores principales: Escande, Carlos, Nin, Veronica, Price, Nathan L., Capellini, Verena, Gomes, Ana P., Barbosa, Maria Thereza, O’Neil, Luke, White, Thomas A., Sinclair, David A., Chini, Eduardo N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609577/
https://www.ncbi.nlm.nih.gov/pubmed/23172919
http://dx.doi.org/10.2337/db12-1139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609577/
https://www.ncbi.nlm.nih.gov/pubmed/23172919
http://dx.doi.org/10.2337/db12-1139

Ejemplares similares